"At the 2016 aasld meeting, most hdv/hbv combo patients were getting close to the end of treatment. Of these almost 50% still had a very high antibody level. By now the true follow up is in progress and I hope we can also see some of ..."
Are you sure you want to delete your ?
You will no longer be able to add new data to this tracker.